EVIO, Inc. Enters into Letter of Intent to Acquire Leading Edge Pharms, Inc.
Cannabis Law Report
JULY 13, 2021
LEP is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems that provide safe and effective topical solutions for pain management. LEP) of Henderson, Nevada. from 2021 to 2028. For more information, visit www.eviolabs.com.
Let's personalize your content